Compliant communication for clinical research studies.

A GDPR-compliant platform for sending templated messages, reminders, and conversational follow-ups to study participants — across WhatsApp, Signal, email, SMS, and Telegram. In active use at a Dutch academic medical center.

  • GDPR-compliant by design
  • Approved for use in academic clinical research
  • EU-hosted, ISO 27001:2022 infrastructure
Download compliance summary Request demo access

Reach participants where they are

  • WhatsApp
  • Signal
  • Telegram
  • SMS
  • Email

What it does

What researchers do with it

demo.research-platform.local / hub
Communication Hub interface showing a conversation thread between researcher and participant via WhatsApp channel, with a 24-hour message-window indicator

Send messages where participants already are

Reach participants on WhatsApp, Signal, Telegram, email, or SMS — based on each participant's preference. Templates for common research communication patterns: enrollment confirmations, consent reminders, follow-up questionnaires, scheduling.

demo.research-platform.local / api-monitor
API monitor showing webhook events with a raw JSON payload drill-down for a delivered WhatsApp message

Track every conversation

Full message history per participant. Searchable audit trail of who saw what and when. Real-time webhook monitoring with raw payload drill-down for incident review.

demo.research-platform.local / studies
Study detail view with participant table showing consent badges (granted, pending, withdrawn) and summary cards for participant counts and recent message activity

Manage studies, groups, and consent

Hierarchical structure from institution down to individual participants. Consent verified before every outbound message. Role-based access for institution admins, study admins, and researchers.

Compliance & security

Built to clear hospital compliance reviews

Hospital privacy officers and clinical research offices have a compliance bar. The platform is built to clear it.

EU-hosted, ISO-certified

Hetzner data centers in Germany and Finland, certified to ISO/IEC 27001:2022. Data Processing Agreement in place.

Encrypted at rest and in transit

Disk-level encryption on all servers. TLS forced on all endpoints. Configurable message retention with automated cleanup.

Per-study Data Processing Agreement

A processing agreement is signed with each executing institution before participants are onboarded.

WhatsApp transfer basis

WhatsApp communication runs on Meta Cloud API. Transatlantic data transfer is covered under the EU–US Data Privacy Framework.

Comprehensive audit logging

All user actions, data views, exports, and message activity are logged for incident review and formal audits.

In active academic use

Used in a clinical research approved by the ethics committee at a Dutch academic medical center.

Full compliance details available in the downloadable summary.

Demo access

Demo access on request

A demo environment with realistic — but entirely fictional — data is available for researchers, privacy officers, and clinical research offices evaluating the platform for their institution.

Request demo access

Research-led

Research-led platform

This platform is led by a clinical researcher who uses it himself. The roadmap reflects what working researchers ask for, not what a product team imagines.

Portrait of Dr. Robert de Leeuw at Amsterdam UMC

Dr. R.A. (Robert) de Leeuw, MD, PhD

Gynaecologist · Principal Investigator

Amsterdam UMC

Robert is a medical specialist in (uro-)gynaecology at Amsterdam UMC, affiliated with the Amsterdam Reproduction & Development research institute. His PhD focused on digital postgraduate medical education; his current research spans eHealth applications for adolescent menstrual health, AI and advanced gynaecological imaging, neuropelveology, and surgical innovation.

He heads the Amsterdam Neuropelveology Center, serves as deputy head of the Endometriosis Center, and chairs the Dutch Adolescent Network. He is the founder of Stichting Women's Health, the foundation that operates this platform.

As a working researcher, Robert built this platform around the gaps he encountered in existing clinical trial infrastructure: participants and researchers needed compliant communication, and the established EDC vendors didn't deliver it.

103 publications 1,549 citations ORCID 0000-0002-9344-7754

Contact

Get in touch

Whether you have questions about compliance, want demo access, or are scoping a pilot for your institution — we'd like to hear from you.

Email us at contact@stichtingvrouwenzorg.nl

We typically respond within two working days.